Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) insider Lisa Khorey sold 15,000 shares of Allscripts Healthcare Solutions stock in a transaction on Wednesday, November 18th. The shares were sold at an average price of $12.75, for a total value of $191,250.00. Following the completion of the transaction, the insider now owns 251,626 shares of the company’s stock, valued at $3,208,231.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Lisa Khorey also recently made the following trade(s):

  • On Wednesday, October 14th, Lisa Khorey sold 15,000 shares of Allscripts Healthcare Solutions stock. The shares were sold at an average price of $11.04, for a total value of $165,600.00.

Shares of NASDAQ:MDRX opened at $13.17 on Friday. Allscripts Healthcare Solutions, Inc. has a 1 year low of $4.56 and a 1 year high of $13.29. The company has a market cap of $2.08 billion, a PE ratio of -43.90, a P/E/G ratio of 3.05 and a beta of 0.94. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.27 and a quick ratio of 0.78. The stock’s 50-day moving average is $10.45 and its 200 day moving average is $8.25.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last announced its quarterly earnings results on Tuesday, November 3rd. The software maker reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.01. Allscripts Healthcare Solutions had a positive return on equity of 5.80% and a negative net margin of 2.77%. The company had revenue of $402.00 million for the quarter, compared to the consensus estimate of $419.75 million. During the same quarter in the previous year, the business earned $0.17 EPS. Allscripts Healthcare Solutions’s revenue was down 9.7% compared to the same quarter last year. Analysts expect that Allscripts Healthcare Solutions, Inc. will post 0.49 EPS for the current fiscal year.

A number of large investors have recently made changes to their positions in MDRX. First Trust Advisors LP grew its holdings in shares of Allscripts Healthcare Solutions by 110.5% during the 1st quarter. First Trust Advisors LP now owns 79,028 shares of the software maker’s stock worth $754,000 after acquiring an additional 41,492 shares during the period. Advisor Group Holdings Inc. purchased a new position in shares of Allscripts Healthcare Solutions during the 1st quarter worth approximately $34,000. State Street Corp grew its holdings in shares of Allscripts Healthcare Solutions by 5.3% during the 1st quarter. State Street Corp now owns 5,468,496 shares of the software maker’s stock worth $38,498,000 after acquiring an additional 277,072 shares during the period. Envestnet Asset Management Inc. purchased a new position in shares of Allscripts Healthcare Solutions during the 2nd quarter worth approximately $73,000. Finally, New York State Teachers Retirement System grew its holdings in shares of Allscripts Healthcare Solutions by 20.3% during the 2nd quarter. New York State Teachers Retirement System now owns 377,761 shares of the software maker’s stock worth $2,557,000 after acquiring an additional 63,733 shares during the period.

Several equities analysts recently commented on MDRX shares. Morgan Stanley boosted their target price on Allscripts Healthcare Solutions from $6.00 to $8.00 and gave the stock an “underweight” rating in a research report on Tuesday, August 11th. ValuEngine cut Allscripts Healthcare Solutions from a “hold” rating to a “sell” rating in a research report on Monday, October 12th. Argus upgraded Allscripts Healthcare Solutions from a “hold” rating to a “buy” rating and set a $14.00 target price for the company in a research report on Wednesday, November 11th. SVB Leerink lifted their price target on Allscripts Healthcare Solutions from $10.00 to $13.00 and gave the stock a “market perform” rating in a research note on Wednesday, October 14th. Finally, Cantor Fitzgerald lifted their price target on Allscripts Healthcare Solutions from $9.00 to $13.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 14th. Six research analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have given a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $10.09.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Story: Why do commodities matter?

Insider Buying and Selling by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions and related companies with MarketBeat.com's FREE daily email newsletter.